ETV1 blocking peptide product blog
Tags: Blocking Peptide; ETV1; ETV1 blocking peptide;
The ETV1 etv1 (Catalog #MBS9230097) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The ETV1 etv1 product has the following accession number(s) (GI #12643411) (NCBI Accession #P50549.2) (Uniprot Accession #P50549). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Transcriptional activator that binds to DNA sequences containing the consensus pentanucleotide 5\'-CGGA[AT]-3\'.
Cellular Location: Nucleus. Tissue Location: Very highly expressed in brain, highly expressed in testis, lung and heart, moderately in spleen, small intestine, pancreas and colon, weakly in liver, prostate and thymus, very weakly in skeletal muscle, kidney and ovary and not in placenta and peripheral blood leukocytes. ETV1 also interacts with the following gene(s): PAX6, RFWD2, RPS6KA1. The following patways have been known to be associated with this gene. Bone, Brain, Embryonic Tissue, Ganglia, Lung, Muscle, Pancreas, Prostate, Skin, Vascular tissues are correlated with this protein. Breast Neoplasms, Cell Transformation, Neoplastic, Congenital Abnormalities, Disease Models, Animal, Hyperplasia, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases, Prostatic Diseases, Prostatic Neoplasms are some of the diseases may be linked to ETV1 Blocking Peptide (N-Term).